NRX Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRXP and other ETFs, options, and stocks.

About NRXP

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases.

CEO

Jonathan C. Javitt

CEOJonathan C. Javitt

Employees

—

Employees—

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

2017

Founded2017

Employees

—

Employees—

NRXP Key Statistics

Market cap

41.00M

Market cap41.00M

Price-Earnings ratio

-1.00

Price-Earnings ratio-1.00

Dividend yield

—

Dividend yield—

Average volume

360.15K

Average volume360.15K

High today

$2.49

High today$2.49

Low today

$2.16

Low today$2.16

Open price

$2.25

Open price$2.25

Volume

582.69K

Volume582.69K

52 Week high

$6.01

52 Week high$6.01

52 Week low

$1.10

52 Week low$1.10

People also own

Based on the portfolios of people who own NRXP. This list is generated using Robinhood data, and it’s not a recommendation.